(Q33383355)

26 July 2017

1 reference

title

Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment (English)

1 reference

26 July 2017

4

Hillard M Lazarus

1 reference

26 July 2017

Cecilia M Choi

1

1 reference

26 July 2017

Alvin H Schmaier

series ordinal

2

1 reference

26 July 2017

Michael R Snell

series ordinal

3

1 reference

26 July 2017

publication date

1 January 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

69

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

183-198

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200969020-00004

26 July 2017

exact match

0 references

cites work

Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969020-00004

Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969020-00004

Brief communication: Successful treatment of pure red-cell aplasia with an anti-interleukin-2 receptor antibody (daclizumab).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969020-00004

Defibrotide Protects Endothelial Cells, but not L929 Tumour Cells, from Tumour Necrosis Factor-α-mediated Cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969020-00004

Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200969020-00004

The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.

21 January 2018

1 reference

12 December 2020

Complete resolution of transplantation-associated thrombotic microangiopathy and hepatic veno-occlusive disease by defibrotide and plasma exchange

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma

1 reference

12 December 2020

Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation

1 reference

12 December 2020

Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients

1 reference

12 December 2020

Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease

1 reference

12 December 2020

Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver

1 reference

12 December 2020

Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins

1 reference

12 December 2020

Protective effect of defibrotide on perfusion induced endothelial damage

1 reference

12 December 2020

Significance of elevation in cell-derived microparticles after allogeneic stem cell transplantation: transient elevation of platelet-derived microparticles in TMA/TTP

1 reference

12 December 2020

Stem cell transplantation nephropathy: a report of six cases

1 reference

12 December 2020

Cyclosporine-induced detachment of vascular endothelial cells initiates the intrinsic coagulation system in plasma and whole blood

1 reference

12 December 2020

Successful treatment of bone marrow transplant--associated thrombotic microangiopathy with antithrombin-III

1 reference

12 December 2020

Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A.

1 reference

12 December 2020

Atypical haemolytic uraemic syndrome

1 reference

12 December 2020

Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients

1 reference

12 December 2020

Procoagulant microparticles: disrupting the vascular homeostasis equation?

1 reference

12 December 2020

Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences

1 reference

12 December 2020

Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide

1 reference

12 December 2020

Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events

1 reference

12 December 2020

Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation

1 reference

12 December 2020

Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?

1 reference

12 December 2020

Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders

1 reference

12 December 2020

Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications

1 reference

12 December 2020

Nephrotoxicity of cyclosporin A after allogeneic marrow transplantation: glomerular thromboses and tubular injury

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura: outcome in 24 patients with renal impairment treated with plasma exchange. Canadian Apheresis Study Group

1 reference

12 December 2020

Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation

1 reference

12 December 2020

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

1 reference

12 December 2020

Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome

1 reference

12 December 2020

Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation.

1 reference

12 December 2020

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta

1 reference

12 December 2020

Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation

1 reference

12 December 2020

Decrease in circulating endothelial cell adhesion molecule and thrombomodulin levels during oral iloprost treatment in rheumatoid arthritis patients: preliminary results

1 reference

12 December 2020

The course of ADAMTS-13 activity and inhibitor titre in the treatment of thrombotic thrombocytopenic purpura with plasma exchange and vincristine

1 reference

12 December 2020

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

1 reference

12 December 2020

Treatment of sinusoidal obstruction syndrome with defibrotide: a single-center experience

1 reference

12 December 2020

Vascular endothelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantation

1 reference

12 December 2020

Thrombotic microangiopathy in transplantation and malignancy

1 reference

12 December 2020

Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome following allogeneic bone marrow transplantation

1 reference

12 December 2020

Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab

1 reference

12 December 2020

Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO)

1 reference

12 December 2020

Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.

1 reference

12 December 2020

Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids.

1 reference

12 December 2020

Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review

1 reference

12 December 2020

von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura.

1 reference

12 December 2020

Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.

1 reference

12 December 2020

Transplantation-associated thrombotic microangiopathy: twenty-two years later

1 reference

12 December 2020

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Rituximab as preventive therapy of a clinical relapse in TTP with ADAMTS13 inhibitor

1 reference

12 December 2020

Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival

1 reference

12 December 2020

Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation

1 reference

12 December 2020

Hemostatic/fibrinolytic protein changes in C3H/HeN mice infected with Rickettsia conorii--a model for Rocky Mountain spotted fever

1 reference

12 December 2020

Thrombotic microangiopathy following bone marrow transplantation.

1 reference

12 December 2020

Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells

1 reference

12 December 2020

Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome

1 reference

12 December 2020

Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia

1 reference

12 December 2020

Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress

1 reference

12 December 2020

Daclizumab to prevent rejection after cardiac transplantation

1 reference

12 December 2020

Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia

1 reference

12 December 2020

von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome

1 reference

12 December 2020

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease.

1 reference

12 December 2020

Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease.

1 reference

12 December 2020

Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease

1 reference

12 December 2020

Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab

1 reference

12 December 2020

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced

1 reference

12 December 2020

Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes

1 reference

12 December 2020

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease

1 reference

12 December 2020

Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis

1 reference

12 December 2020

Hepatic veno-occlusive disease (VOD) with complete occlusion of liver venules after tandem autologous stem cell transplantation-- successful treatment with high-dose methylprednisolone and defibrotide

1 reference

12 December 2020

Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation

1 reference

12 December 2020

Humanized anti-CD25 antibody treatment with daclizumab in multiple sclerosis.

1 reference

12 December 2020

Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Polydeoxyribonucleotide (defibrotide) protects against post-ischemic behavioral, electroencephalographic and neuronal damage in the gerbil.

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT).

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases

1 reference

12 December 2020

Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura: a moving target

1 reference

12 December 2020

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group

1 reference

12 December 2020

The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation.

1 reference

12 December 2020

Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).

1 reference

12 December 2020

1 reference

12 December 2020

Inhibitory effect of conjugated eicosapentaenoic acid on mammalian DNA polymerase and topoisomerase activities and human cancer cell proliferation

1 reference

12 December 2020

Clinical practice. Thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells.

1 reference

12 December 2020

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: review and update on the use of defibrotide

1 reference

12 December 2020

Changes of clotting factors (7, 9 and 10) and hepatocyte growth factor in patients with thrombotic microangiopathy after bone marrow transplantation

1 reference

12 December 2020

Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer

1 reference

12 December 2020

Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease

1 reference

12 December 2020

Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura associated with renal failure after autologous transplantation for multiple myeloma successfully treated with rituximab

1 reference

12 December 2020

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group

1 reference

12 December 2020

Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention

1 reference

12 December 2020

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

12 December 2020

Hepatic veno-occlusive disease

1 reference

12 December 2020

Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants.

1 reference

12 December 2020

Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

1 reference

12 December 2020

Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy

1 reference

12 December 2020

Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angiopl

1 reference

12 December 2020

Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes

1 reference

12 December 2020

Daclizumab has poor efficacy in steroid-refractory severe acute graft-versus-host disease: a single centre experience with 12 allograft patients

1 reference

12 December 2020

ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy

1 reference

12 December 2020

Oral eicosapentaenoic acid for complications of bone marrow transplantation

1 reference

12 December 2020

Effects of atorvastatin on arterial endothelial function in coronary bypass surgery

1 reference

12 December 2020

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

1 reference

12 December 2020

The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans

1 reference

12 December 2020

Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis

1 reference

12 December 2020

Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results

1 reference

12 December 2020

Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

VEGF inhibition and renal thrombotic microangiopathy

1 reference

12 December 2020

Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide

1 reference

12 December 2020

Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?

1 reference

12 December 2020

Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide

1 reference

12 December 2020

Daclizumab prevents acute rejection and improves patient survival post transplantation: 1 year pooled analysis

1 reference

12 December 2020

A case report of thrombotic thrombocytopenic purpura and severe acute renal failure post non-myeloablative allogeneic peripheral blood stem cell transplantation treated with plasma exchange and hemodialysis

1 reference

12 December 2020

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

1 reference

12 December 2020

Anaphylactic shock to defibrotide

1 reference

12 December 2020

Defibrotide in recurrent thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation

1 reference

12 December 2020

Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation

1 reference

12 December 2020

von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem cell transplantation

1 reference

12 December 2020

ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Bone marrow transplant-associated thrombotic microangiopathy: a case series.

1 reference

12 December 2020

The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

12 December 2020

Management of thrombotic microangiopathy following allogeneic transplantation: what is the role of plasma exchange?

1 reference

12 December 2020

Endothelial damage caused by cytomegalovirus and human herpesvirus-6.

1 reference

12 December 2020

Defibrotide for the treatment of hepatic veno-occlusive disease in children

1 reference

12 December 2020

Life-threatening hemolytic-uremic syndrome treated with rituximab in an allogeneic bone marrow transplant recipient

1 reference

12 December 2020

Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells

1 reference

12 December 2020

Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.

1 reference

12 December 2020

Daclizumab: outcome of phase III trials and mechanism of action. Double Therapy and the Triple Therapy Study Groups

1 reference

12 December 2020

10.2165/00003495-200969020-00004

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1009621806

0 references

1 reference